Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Fast track designation for Tocosol Paclitaxel

Oct. 31, 2003

Oncolytics Biotech and NCI enter collaborative agreement for Reolysin

Oct. 31, 2003

New pyrrole-based photosensitizers and their use in cancer therapy

Oct. 31, 2003

Novel FTase inhibitors prepared and tested at Janssen

Oct. 31, 2003

Recombinant human angiostatin well tolerated in cancer patients

Oct. 31, 2003

Acceptable safety profile described for oral diflomotecan in solid tumors

Oct. 31, 2003

Targeted therapy of AML with anti-FLT3 antibody under evaluation

Oct. 30, 2003

Canadian approval for Gleevec for newly diagnosed Ph+ CML

Oct. 30, 2003

Sankyo intensifies development of anticancer drugs

Oct. 30, 2003

New inhibitors of ZAP-70, FAK and/or Syk designed at Novartis

Oct. 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.